Skip to main content

Table 1 Patients characteristics

From: Langerhans cells in hypospadias: an analysis of Langerin (CD207) and HLA-DR on epidermal sheets and full thickness skin sections

 

all patients (n = 43)

Linz

(n = 32)

Gent

(n = 11)

p

age at surgery mean/median [months]

49 / 15

36 / 15

26 / 14

0.4a

no penile malformation (%)

13 (30.2%)

12 (37.5%)

1 (9.1%)

 

hypospadias

26 (60.4%)

19 (59.4%)

7 (63.6%)

 

 distal hypospadias (% of all hypospadias)

16 (61.5%)

11 (57.9%)

5 (71.4%)

 

 proximal hypospadias (% of all hypospadias)

10 (38.5%)

8 (42.1)

2 (28.6%)

 

 thereof with preoperative androgen treatment (local DHTb for 6 weeks until 4 weeks before surgery)

7 (70%)

7 (87.5%)

0

 

other penile malformations

4 (9.3%)

1 (3.1%)

3 (27.2%)

 

 buried penis

2 (50%)

0

2 (66.6%)

 

 epispadias

2 (50%)

1 (100%)

1 (33.3%)

 
  1. astudents t-test b Dihydrotestosterone, applied twice daily